APA (7th ed.) Citation

Li, R., Zhu, X., Zhu, X., Zhou, P., Qiao, Y., Li, Y., . . . Shi, X. (2022). Generation of a High-Affinity Nanobody Against CD147 for Tumor Targeting and Therapeutic Efficacy Through Conjugating Doxorubicin. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Li, Rifei, Xinjie Zhu, Xinjie Zhu, Peng Zhou, Yuehua Qiao, Yinqian Li, Yice Xu, and Xi Shi. Generation of a High-Affinity Nanobody Against CD147 for Tumor Targeting and Therapeutic Efficacy Through Conjugating Doxorubicin. Frontiers Media S.A, 2022.

MLA (9th ed.) Citation

Li, Rifei, et al. Generation of a High-Affinity Nanobody Against CD147 for Tumor Targeting and Therapeutic Efficacy Through Conjugating Doxorubicin. Frontiers Media S.A, 2022.